BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7340714)

  • 1. [Screening for breast cancer (author's transl)].
    De Waard F; Rombach JJ; Collette HJ
    Arch Geschwulstforsch; 1981; 51(8):685-9. PubMed ID: 7340714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical detection of 2,511 breast cancers 1977-1986. Efficiency of legal early cancer detection studies].
    Leonhardt A
    Geburtshilfe Frauenheilkd; 1988 Feb; 48(2):92-8. PubMed ID: 3366351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
    Duijm LE; Groenewoud JH; Roumen RM; de Koning HJ; Plaisier ML; Fracheboud J
    Breast Cancer Res Treat; 2007 Nov; 106(1):113-9. PubMed ID: 17219049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast cancer detected by mass screening using physical examination alone].
    Morimoto T; Komaki K; Monden Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):944-51. PubMed ID: 3389838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audit of a breast cancer screening programme using clinical examination and lightscanning.
    Braddick MR
    Health Bull (Edinb); 1991 Nov; 49(6):299-303. PubMed ID: 1765479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for breast cancer in women aged 41--60.
    Soini I; Lauslahti K
    Ann Clin Res; 1976 Dec; 8(6):403-7. PubMed ID: 1008478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast complaints during the Dutch nationwide breast cancer screening program: increased risk of referral and of breast cancer].
    van Bon-Martens MJ; Klingenberg H; Dijkstra HA; Peeters PH
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1067-71. PubMed ID: 11414168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass screening for breast cancer.
    Strax P
    Rev Fr Gynecol Obstet; 1973 Jun; 68(6):457-66. PubMed ID: 17474655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995].
    van Dijck JA; Hendriks JH; Holland R; Schouten LJ; Verbeek AL
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1119-24. PubMed ID: 10876707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary nodal status in women with screen-detected breast cancer.
    Ranaboldo CJ; Mitchel A; Royle GT; Theaker GM; Taylor I
    Eur J Surg Oncol; 1993 Apr; 19(2):130-3. PubMed ID: 8491316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening clinical breast examination: how often does it miss lethal breast cancer?
    Fenton JJ; Barton MB; Geiger AM; Herrinton LJ; Rolnick SJ; Harris EL; Barlow WE; Reisch LM; Fletcher SW; Elmore JG
    J Natl Cancer Inst Monogr; 2005; (35):67-71. PubMed ID: 16287888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
    Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
    Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
    Petrik DW; McCready DR; Sawka CA; Goel V
    J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Population screening for breast cancer: an interim assessment].
    van der Maas PJ
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1096-9. PubMed ID: 10876703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early detection of breast cancer by mass screening using mammography].
    Morimoto T; Sasa M; Yamaguchi T; Harada K; Kondo H; Kuroda R
    Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():158-63. PubMed ID: 8037479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.